Jörn Aldag

Jörn Aldag leads the board of Molecular Partners. He is CEO of Hookipa Biotech AG, Vienna, a company developing innovative active immunization therapies for infectious diseases and immuno-oncology. Previously, Mr. Aldag was the CEO …

MORE

Dr. Göran Ando

Dr. Göran Ando is Chairman of the board of directors of Novo Nordisk A/S. He was CEO of Celltech Group plc, UK, until 2004. Dr. Ando joined Celltech from Pharmacia, now Pfizer, US, where he was Executive Vice President …

MORE

Jeffrey H. Buchalter

Jeffrey H. Buchalter is the Chairman and Chief Executive Officer of KBS Healthcare Consulting, Florida, and he serves as Chairman of the board of directors of UK-based Inivata Ltd. Mr. Buchalter served in various senior executive positions, including being CEO of NASDAQ-listed Enzon …

MORE

Steven H. Holtzman

Steven H. Holtzman joined Decibel Therapeutics as president and chief executive officer in 2016. Decibel discovers and develops novel therapeutic approaches to treat hearing loss and other hearing disorders …

MORE

Dr. William A. Lee

Dr. William “Bill” Lee is Executive Vice President Research at Gilead Sciences. Dr. Lee joined Gilead as Director of Pharmaceutical Product Development in 1991. Prior to joining Gilead, he was Department Head …

MORE

Prof. Dr. Andreas Plückthun

Prof. Dr. Andreas Plückthun is Full Professor at the Department of Biochemistry at the University of Zurich and a co-founder of Molecular Partners (2004), the German biotechnology company MorphoSys …

MORE

Dr. Petri Vainio

Petri Vainio, MD, PhD has spent his entire career as an investor and board member in rapidly growing healthcare companies. He has been a lead investor in numerous successful healthcare companies in all sectors, including pharmaceuticals, biotechnology …

MORE

Dr. Gwen Fyfe

Gwen Fyfe, MD, has more than 20 years of drug development experience in oncology. She held various positions at Genentech from 1997-2009, including vice president, oncology development, playing an important role in the development of Genentech’s approved oncology agents including Rituxan®, Herceptin®, Avastin® and Tarceva® …

MORE

 

Audit and Finance Committee

Nomination and Compensation Committee

Science Committee         

Dr. Petri Vainio (Chairperson)

Jörn Aldag (Chairperson)

Dr. William A. Lee (Chairperson)

Jörn Aldag

Dr. William A. Lee

Dr. Gwen Fyfe

Jeffrey H. Buchalter

Dr. Petri Vainio

Prof. Dr. Andreas Plückthun

 

Honorary Chairman of the Board of Directors

 

Dr. Christian Zahnd

Dr. Christian Zahnd is the Honorary Chairman of the Board of Directors of Molecular Partners. Dr. Zahnd co-founded the Company to expand his pioneering research on the therapeutic applications of DARPins …

MORE